(19)
(11) EP 1 173 590 A2

(12)

(88) Date of publication A3:
15.02.2001

(43) Date of publication:
23.01.2002 Bulletin 2002/04

(21) Application number: 00922167.2

(22) Date of filing: 13.04.2000
(51) International Patent Classification (IPC)7C12N 15/62, C12N 15/57, C12N 15/63, C12N 15/79
(86) International application number:
PCT/US0009/973
(87) International publication number:
WO 0066/709 (09.11.2000 Gazette 2000/45)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 30.04.1999 US 303162

(71) Applicant: Ortho-McNeil Pharmaceutical, Inc.
Raritan, NJ 08869 (US)

(72) Inventors:
  • DARROW, Andrew
    Lansdale, PA 19446 (US)
  • QI, Jensen
    Branchburg, NJ 08876 (US)
  • ANDRADE-GORDON, Patricia
    Doylestown, PA 18901 (US)

(74) Representative: Mercer, Christopher Paul et al
Carpmaels & Ransford 43, Bloomsbury Square
London WC1A 2RA
London WC1A 2RA (GB)

   


(54) ZYMOGEN ACTIVATION SYSTEM